| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/01/2022 | 170.91% | Loop Capital | → $23 | Initiates Coverage On | → Buy |
| 01/10/2022 | 512.49% | Cantor Fitzgerald | → $52 | Initiates Coverage On | → Overweight |
| 01/10/2022 | 100.24% | Evercore ISI Group | → $17 | Initiates Coverage On | → Outperform |
| 01/10/2022 | 147.35% | Berenberg | → $21 | Initiates Coverage On | → Buy |
Bionomics Questions & Answers
The latest price target for Bionomics (NASDAQ: BNOX) was reported by Loop Capital on November 1, 2022. The analyst firm set a price target for $23.00 expecting BNOX to rise to within 12 months (a possible 170.91% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Bionomics (NASDAQ: BNOX) was provided by Loop Capital, and Bionomics initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionomics was filed on November 1, 2022 so you should expect the next rating to be made available sometime around November 1, 2023.
While ratings are subjective and will change, the latest Bionomics (BNOX) rating was a initiated with a price target of $0.00 to $23.00. The current price Bionomics (BNOX) is trading at is $8.49, which is within the analyst's predicted range.